EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
12.50
-0.56 (-4.29%)
Mar 27, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Jun '18 Jun '17
Developing and Commercializing Innovative Ophthalmic Products
31.37M43.27M46.02M41.40M36.94M
Developing and Commercializing Innovative Ophthalmic Products Growth
-27.50%-5.97%11.14%12.09%7.27%
Total
31.37M43.27M46.02M41.40M36.94M
Total Growth
-27.50%-5.97%11.14%12.09%7.27%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Jun '18 Jun '17
United States (U.S.)
29.98M42.05M45.27M40.48M35.99M
United States (U.S.) Growth
-28.70%-7.12%11.83%12.48%59.07%
China
1.29M1.12M648.00K823.00K851.00K
China Growth
14.95%73.46%-21.26%-3.29%-92.73%
United Kingdom (U.K.)
100.00K100.00K100.00K100.00K100.00K
United Kingdom (U.K.) Growth
0%0%0%0%0%
Total
31.37M43.27M46.02M41.40M36.94M
Total Growth
-27.50%-5.97%11.14%12.09%7.27%
Source: S&P Global Market Intelligence.